Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180108038263N1Phase 3Completed
Phase 3, randomised, single-blind trial of propofol, sevoflurane and nitrous oxide (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Forced vital capacity, Forced expiratory volume in 1 second and 1 more. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180108038263N1.